BioGaia eyes Argentina after Egyptian pull-out

Related tags United states

Sweden’s BioGaia has announced an agreement with Ferring Pharmaceuticals in Argentina to launch probiotic drops and tablets in Argentina, while simultaneously discontinuing an agreement in Egypt.

The agreement, which adds to existing ties between the companies covering a host of Latin American countries, will see the drops and tablets launched under the BioGaia brand during the first half of 2011.

“Latin America is a relatively new market for us and we are looking forward to launching our products in yet another country in this region,” ​said Peter Rothschild, BioGaia’s president.

The Swedish company has also announced the discontinuation of an agreement with Ferring relating to Egypt. Since signing the agreement in 2008, regulatory difficulties have prevented any products being launched. BioGaia stated that is was therefore discontinuing the agreement with Ferring for Egypt.

Related topics Suppliers

Related news

Follow us

Products

View more

Webinars